Verrica Pharmaceuticals Inc. VRCA
3.21 USD -0.14 -4.18%
At close · Nov 2
3.18 -0.03 -0.80%
After hours · Nov 2, 4:00 PM ET
- YTD
- -61.37%
- 1 year
- -11.08%
- Open
- 3.40
- Prev close
- 3.35
- Mkt cap
- 55.14M
- Vol
- 55.80K
- Avg vol
- 69.92K
- EPS
- -1.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.20
- High
- 3.54
- Forward P/E
- -1.19
- Beta
- 1.46
- Short ratio
- 3.19
- Inst. own
- 15.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 1.12
- 200-d avg
- 4.58
- 1y target
- 6.33
MAX chart
Chart tools
Chart is warming up
The all-time price history for VRCA has not been loaded yet. Try again in a moment.
Altman Z-Score
-13.70 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
P/E -4.9×
P/S 2.5×
P/B 3.6×
P/FCF -5.0×
EV/EBITDA -6.4×
EV/Sales 1.7×
FCF Yield -19.9%
Gross Margin 90.3%
Operating Margin -33.6%
Net Margin -50.3%
ROE -72.3%
ROIC -38.0%
ROA -37.9%
Revenue 370.2%
Operating Income 81.9%
EPS (diluted) 88.6%
Free Cash Flow 71.1%
Current Ratio 2.6×
Quick Ratio 2.5×
Debt / Equity 0.1×
Net Debt / EBITDA 3.0×
Interest Coverage -1.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31